Literature DB >> 24712867

Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement.

A G Lau1, J Sun, W B Hannah, E W Livingston, D Heymann, T A Bateman, P E Monahan.   

Abstract

While chronic degenerative arthropathy is the main morbidity of haemophilia, a very high prevalence of low bone density is also seen in men and boys with haemophilia. This study investigates bone degradation in the knee joint of haemophilic mice resulting from haemarthrosis and the efficacy of aggressive treatment with factor VIII in the period surrounding injury to prevent bone pathology. Skeletally mature factor VIII knock-out mice were subjected to knee joint haemorrhage induced by puncture of the left knee joint capsule. Mice received either intravenous factor VIII treatment or placebo immediately prior to injury and at hours 4, 24, 48, 72 and 96 after haemorrhage. Mice were killed 2-weeks after injury and the joint morphology and loss of bone in the proximal tibia was assessed using microCT imaging. Quantitative microCT imaging of the knee joint found acute bone loss at the proximal tibia following injury including loss of trabecular bone volumetric density and bone mineral density, as well as trabecular connectivity density, number and thickness. Unexpectedly, joint injury also resulted in calcification of the joint soft tissues including the tendons, ligaments, menisci and cartilage. Treatment with factor VIII prevented this bone and soft tissue degeneration. Knee joint haemorrhage resulted in acute changes in adjacent bone including loss of bone density and mineralization of joint soft tissues. The rapid calcification and loss of bone has implications for the initiation and progression of osteoarthritic degradation following joint bleeding.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  bone density; factor VIII; haemarthrosis; joint degradation; microCT; mineralization

Mesh:

Substances:

Year:  2014        PMID: 24712867      PMCID: PMC4396845          DOI: 10.1111/hae.12399

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  36 in total

1.  Reduced bone mineral density in patients with haemophilia A and B in Northern Greece.

Authors:  Panagiotis Anagnostis; Sofia Vakalopoulou; Aristidis Slavakis; Maria Charizopoulou; Eirini Kazantzidou; Tania Chrysopoulou; Timoleon-Achilleas Vyzantiadis; Eleni Moka; Alexandra Agapidou; Vassilia Garipidou
Journal:  Thromb Haemost       Date:  2012-02-08       Impact factor: 5.249

2.  Osteoporosis in haemophilia - an underestimated comorbidity?

Authors:  T A Wallny; D T Scholz; J Oldenburg; C Nicolay; S Ezziddin; P H Pennekamp; B Stoffel-Wagner; C N Kraft
Journal:  Haemophilia       Date:  2007-01       Impact factor: 4.287

3.  IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia.

Authors:  N Narkbunnam; J Sun; G Hu; F-C Lin; T A Bateman; M Mihara; P E Monahan
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

Review 4.  Crosstalk between cartilage and bone: when bone cytokines matter.

Authors:  Thomas Funck-Brentano; Martine Cohen-Solal
Journal:  Cytokine Growth Factor Rev       Date:  2011-05-18       Impact factor: 7.638

5.  RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.

Authors:  Daniela Melchiorre; Anna Franca Milia; Silvia Linari; Eloisa Romano; Gemma Benelli; Mirko Manetti; Serena Guiducci; Claudia Ceccarelli; Massimo Innocenti; Christian Carulli; Roberto Civinini; Massimo Morfini; Marco Matucci-Cerinic; Lidia Ibba-Manneschi
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

6.  Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia.

Authors:  G Gerstner; M L Damiano; A Tom; C Worman; W Schultz; M Recht; A T Stopeck
Journal:  Haemophilia       Date:  2009-02-01       Impact factor: 4.287

7.  Calcium deposition in osteoarthritic meniscus and meniscal cell culture.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; H James Norton; Natalia Zinchenko; Edward N Hanley; Helen E Gruber
Journal:  Arthritis Res Ther       Date:  2010-03-30       Impact factor: 5.156

8.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

9.  Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy.

Authors:  Michel J J Hooiveld; Goris Roosendaal; Kim M G Jacobs; Marieke E Vianen; H Marijke van den Berg; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  Arthritis Rheum       Date:  2004-06

10.  Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

Authors:  Junjiang Sun; Narine Hakobyan; Leonard A Valentino; Brian L Feldman; R Jude Samulski; Paul E Monahan
Journal:  Blood       Date:  2008-08-20       Impact factor: 22.113

View more
  10 in total

1.  Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.

Authors:  Junjiang Sun; Baolai Hua; Eric W Livingston; Sarah Taves; Peter B Johansen; Maureane Hoffman; Mirella Ezban; Dougald M Monroe; Ted A Bateman; Paul E Monahan
Journal:  Blood       Date:  2016-12-30       Impact factor: 22.113

2.  Reduced Osteoarthritis Severity in Aged Mice With Deletion of Macrophage Migration Inhibitory Factor.

Authors:  Meredith A Rowe; Lindsey R Harper; Margaret A McNulty; Anthony G Lau; Cathy S Carlson; Lin Leng; Richard J Bucala; Richard A Miller; Richard F Loeser
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

3.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

4.  Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.

Authors:  Klytaimnistra Kiouptsi; Alexandra Grill; Amrit Mann; Mareike Döhrmann; Maren Lillich; Sven Jäckel; Frano Malinarich; Henning Formes; Davit Manukyan; Saravanan Subramaniam; Avinash Khandagale; Cornelia Karwot; Serge C Thal; Markus Bosmann; Inge Scharrer; Kerstin Jurk; Christoph Reinhardt
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

5.  Hemophilia A and B mice, but not VWF-/-mice, display bone defects in congenital development and remodeling after injury.

Authors:  Sarah Taves; Junjiang Sun; Eric W Livingston; Xin Chen; Jerome Amiaud; Regis Brion; William B Hannah; Ted A Bateman; Dominique Heymann; Paul E Monahan
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 6.  Low Bone Mineral Density in Hemophiliacs.

Authors:  Jennifer Gebetsberger; Michael Schirmer; Walter J Wurzer; Werner Streif
Journal:  Front Med (Lausanne)       Date:  2022-02-02

7.  Drug discovery in spinal cord injury-induced osteoporosis: a text mining-based study.

Authors:  Chenfeng Wang; Yang Xu; Lin Han; Weiqing Wu; Xuhua Lu
Journal:  Ann Transl Med       Date:  2022-07

8.  In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology.

Authors:  K K Vøls; M Kjelgaard-Hansen; C D Ley; A K Hansen; M Petersen
Journal:  BMC Musculoskelet Disord       Date:  2020-04-14       Impact factor: 2.362

9.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

10.  On-demand treatment with the iron chelator deferasirox is ineffective in preventing blood-induced joint damage in haemophilic mice.

Authors:  Astrid E Pulles; Lize F D van Vulpen; Katja Coeleveld; Simon C Mastbergen; Roger E G Schutgens; Floris P J G Lafeber
Journal:  Haemophilia       Date:  2021-05-27       Impact factor: 4.287

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.